Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Irritable Bowel Syndrome

1-anilino-8-naphthalenesulfonate has been researched along with Irritable Bowel Syndrome in 1 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Money, ME1
Hofmann, AF1
Hagey, LR1
Walkowiak, J1
Talley, NJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Pilot Study: Assessment of Gastric and Intestinal Motility Following a Trigger Meal in Patients With Post Prandial Diarrhea[NCT01114113]0 participants (Actual)Interventional2010-04-30Withdrawn (stopped due to Lack of interest in participation by patients locally and lack of funding.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Irritable Bowel Syndrome

ArticleYear
Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea.
    Pancreas, 2009, Volume: 38, Issue:2

    Topics: Aged; Allylamine; Colesevelam Hydrochloride; Diarrhea; Female; Humans; Irritable Bowel Syndrome; Lip

2009